GSK_Annual_Report_2021

Notes to the Consolidated Financial Statements for the year ended March 31, 2021 (contd.) Financial Statements GlaxoSmithKline Pharmaceuticals Limited 216 (b) Dividend distribution and proposed dividend ( ` in lakhs) Year ended March 31, 2021 Year ended March 31, 2020 (i) Equity shares Final dividend for the year ended March 31, 2020 of ` 40 (March 31, 2019: ` 20) per fully paid share 677,62.41 338,81.21 (ii) Dividend Distribution Tax on the above - 69,64.38 (iii) Dividends not recognised at the end of the reporting period In addition to the above dividends, since year end the directors have recommended the payment of a final dividend of ` 30 per fully paid equity share (March 31, 2020: ` 40 per fully paid equity share (including special dividend of ` 20 per equity share)). The proposed dividend for the year ended March 31, 2021 is subject to the approval of shareholders in the ensuing annual general meeting. 508,24.63 677,62.41 (iv) Dividend Distribution Tax on the above (Refer note below) - - Note: With reference to the amendment in the Finance Act 2020, Dividend Distribution Tax (DDT) has been abolished from AY 2021-22. i.e. no DDT shall be payable by the company on any dividend distributed on or after April 1, 2020 and hence there is no DDT on proposed dividend. Note 50 : Segment Reporting An operating segment is one whose operating results are regularly reviewed by the entity’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The Group has identified the Chief Operating Decision Maker as its Managing Director. The Chief Operating Decision Maker reviews performance of pharmaceutical business on an overall basis. As the Group has a single reportable segment, the segment wise disclosure requirements of IndAS 108 on Operating Segment is not applicable. In compliance to the said standard, entity-wide disclosures are as under : ( ` in lakhs) Year ended March 31, 2021 Year ended March 31, 2020 Revenues from external customers attributed to the country of domicile and attributed to all foreign countries from which the group derives revenues Revenue from the Country of Domicile- India 3184,22.92 3206,92.12 Revenue from foreign countries 14,63.30 17,45.95 Total 3198,86.22 3224,38.07 ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 Details of non current asset Non Current asset from the Country of Domicile- India 795,50.49 1235,51.52 Non Current asset from foreign countries - - Total 795,50.49 1235,51.52 Information about major customers The Group did not have any external revenue from a particular customer which exceeded 10% of total revenue.